JRJai Youl Ro

Jai Youl Ro

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jai Youl Ro has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Dae Yong Kim

    Department of Pharmacology, School of Medicine, Sungkyunkwan University, Suwon, Korea

    2 shared publications
  • Gwan Ui Hong

    Department of Pharmacology and SBRI, Sungkyunkwan University School of Medicine, Suwon, Korea

    2 shared publications
  • Bum Soo Park

    Department of Pharmacology and Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, Korea

    1 shared publication
  • Byung Jae Lee

    Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

    1 shared publication
  • Chang Ho Lee

    Department of Pharmacology, College of Medicine, Hanyang University, Seoul, Korea

    1 shared publication
  • Dae Yong Kim

    Department of Pharmacology and Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon 440-726, Korea

    1 shared publication

Latest Publications

  • Transglutaminase 2 expressed in mast cells recruited into skin or bone marrow induces the development of pediatric mastocytosis

    by Young Min Ahn, Gwan Ui Hong, Sang Hoon Kim, Ho Jung Lee, Hey Sung Baek, Myung Nam Kim, Kui Young Park, Jai Youl Ro

    Background: Mastocytosis is characterized by a pathological increase in mast cells in organs such as skin and bone marrow. Transglutaminase 2 (TG2) expressed in mast cells contributes to allergic diseases, but its role in mastocytosis has not been investigated. This study aimed to investigate whether TG2 contributes to pediatric mastocytosis.Methods: Serum, various skin tissues or bone marrow (BM) biopsy and aspirates were obtained from pediatric normal control or patients with indolent systemic mastocytosis (SM), mastocytoma, and urticaria pigmentosa (UP). Tryptase, individual cytokines, leukotriene C4 (LTC4), and TG2 activity in the serum were determined by enzyme‐linked immunosorbent assay, mast cell population by May–Grünwald–Giemsa, CD 117 by immunofluorescence, cell surface molecules by Western blot, and colocalization of c‐kit and TG2 or IL‐10‐expressing cells, CD25, and FOXP3 by immunohistochemistry.Results: Infiltration of CD25+CD117+CD2‐ mast cells into BM and scalp/trunk/ear dermis; expression of FcεRI, tryptase, c‐kit, FOXP3, CCL2/CCR2, and vascular cell adhesion molecule‐1; and colocalization of c‐kit and TG2 were enhanced in patient′s skin tissues or BM, particularly SM, but colocalization of c‐kit and IL‐10‐expressing cells was decreased vs. normal tissues. Amounts of LTC4 and inflammatory cytokines, expression of tryptase or TG2 activity were increased in patient's serum, BM aspirates, or ear/scalp skin tissues, respectively, vs. normal persons, but IL‐10 level was decreased.Conclusion: The data suggest that mast cells, recruited in the skin and BM by CCL2/CCR, may induce the development of pediatric mastocytosis through reducing IL‐10 due to upregulating TG2 activity via transcription factor nuclear factor‐κB. Thus, TG2 may be used in diagnosis of pediatric mastocytosis, particularly SM.


  • Open Access

    Cigarette smoke exacerbates mouse allergic asthma through Smad proteins expressed in mast cells

    by Dae Yong Kim, Eun Young Kwon, Gwan Ui Hong, Yun Song Lee, Seung-Hyo Lee, Jai Youl Ro

    Background: Many studies have found that smoking reduces lung function, but the relationship between cigarette smoke and allergic asthma has not been clearly elucidated, particularly the role of mast cells. This study aimed to investigate the effects of smoke exposure on allergic asthma and its association with mast cells.Methods: BALB/c mice were sensitized and challenged by OVA to induce asthma, and bone marrow-derived mast cells (BMMCs) were stimulated with antigen/antibody reaction. Mice or BMMCs were exposed to cigarette smoke or CSE solution for 1 mo or 6 h, respectively. The recruitment of inflammatory cells into BAL fluid or lung tissues was determined by Diff-Quik or H&E staining, collagen deposition by Sircol assay, penh values by a whole-body plethysmography, co-localization of tryptase and Smad3 by immunohistochemistry, IgE and TGF-β level by ELISA, expressions of Smads proteins, activities of signaling molecules, or TGF-β mRNA by immunoblotting and RT-PCR.Results: Cigarette smoke enhanced OVA-specific IgE levels, penh values, recruitment of inflammatory cells including mast cells, expressions of smad family, TGF-β mRNA and proteins, and cytokines, phosphorylations of Smad2 and 3, and MAP kinases, co-localization of tryptase and Smad3, and collagen deposition more than those of BAL cells and lung tissues of OVA-induced allergic mice. CSE solution pretreatment enhanced expressions of TGF-β, Smad3, activities of MAP kinases, NF-κB/AP-1 or PAI-1 more than those of activated-BMMCs.Conclusions: The data suggest that smoke exposure enhances antigen-induced mast cell activation via TGF-β/Smad signaling pathways in mouse allergic asthma, and that it exacerbates airway inflammation and remodeling.


  • Open Access

    Anti‐inflammatory effects of the R2 peptide, an inhibitor of transglutaminase 2, in a mouse model of allergic asthma, induced by ovalbumin

    by Dae Yong Kim, Bum Soo Park, Gwan Ui Hong, Byung Jae Lee, Jung Won Park, Soo Youl Kim, Jai Youl Ro

    BACKGROUND AND PURPOSE Transglutaminase 2 (TGase 2) expression is increased in inflammatory diseases, and TGase 2 inhibitors block these increases. We examined whether the R2 peptide inhibited the expression of TGase 2 in a mouse model of inflammatory allergic asthma.EXPERIMENTAL APPROACH C57BL/6 mice were sensitized and challenged by ovalbumin (OVA) to induce asthma. OVA‐specific serum IgE and leukotrienes (LTs) levels were measured by enzyme‐linked immunosorbent assay. Recruitment of inflammatory cells into bronchoalveolar lavage (BAL) fluid or lung tissues and goblet cell hyperplasia were assessed histologically. Airway hyperresponsiveness was determined in a barometric plethysmographic chamber. Expression of TGase 2, eosinophil major basic protein (EMBP), the adhesion molecule vascular cell adhesion molecule‐1, Muc5ac and phospholipase A2 (PLA2) protein were determined by Western blot. Expression of mRNAs of Muc5ac, cytokines, matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs) were measured by reverse transcriptase‐polymerase chain reaction and nuclear factor‐κB (NF‐κB) by electrophoretic mobility shift assay.KEY RESULTS R2 peptide reduced OVA‐specific IgE levels; the number of total inflammatory cells, macrophages, neutrophils, lymphocytes and eosinophils in BAL fluid and the number of goblet cells. Airway hyperresponsiveness, TGase 2 and EMBP levels, mRNA levels of interleukin (IL)‐4, IL‐5, IL‐6, IL‐8, IL‐13, RANTES, tumour necrosis factor‐α, and MMP2/9, Muc5ac, NF‐κB activity, PLA2 activity and expressions, and LT levels in BAL cells and lung tissues were all reduced by R2 peptide. R2 peptide also restored expression of TIMP1/2.CONCLUSION AND IMPLICATIONS R2 peptide reduced allergic responses by regulating NF‐κB/TGase 2 activity in a mouse model of allergic asthma. This peptide may be useful in the treatment of allergic asthma.


  • Open Access

    Signal Pathway of Cytokines Produced by Reactive Oxygen Species Generated from Phorbol Myristate Acetate‐Stimulated HMC‐1 Cells

    by J. Y. Kim, J. Y. Ro

    The relationship of cytokine production and reactive oxygen species (ROS) generated in mast cells has not been reported yet. This study aimed to examine the signal pathway in the production of cytokines [interleukin‐8 (IL‐8) and tumour necrosis factor‐α (TNF‐α)] by ROS generated from phorbol myristate acetate (PMA)‐stimulated human mast cell line‐1 cells (HMC‐1). HMC‐1 cells were stimulated with 25 ng/ml of PMA. The ROS generation and production of cytokines (IL‐8 and TNF‐α) were measured by fluorescence‐activated cell sorter and enzyme‐linked immunosorbent assay method, respectively. Phosphorylation of mitogen‐activated protein kinase family (extracellular signal‐regulated kinase, p38 and c‐Jun N‐terminal kinase) was detected by the Western blotting method. The expression of cytokine's mRNA was measured by reverse transcriptase – polymerase chain reaction, and the DNA‐binding activity of the transcription factors [nuclear factor‐κB (NF‐κB) and activator protein‐1] was detected by electrophoretic mobility shift assay. PMA‐stimulated HMC‐1 cells immediately generated ROS, and the generated ROS was inhibited by 1,3‐dimethyl‐2‐thiourea (DMTU), but partially inhibited by catalase orN‐acetyl‐l‐cysteine. The production of cytokines in PMA‐stimulated HMC‐1 cells reached the maximum at 3–5 h and was inhibited by DMTU and specific kinase inhibitor for p38, SB203580. DMTU and SB203580 also inhibited the expressed cytokine's mRNA level and the increased DNA‐binding activity of transcription factors, NF‐κB in PMA‐stimulated HMC‐1 cells. These data suggest that intracellular ROS generated from PMA‐stimulated HMC‐1 cells contributes to the production of inflammatory cytokines via p38 kinase/NF‐κB.